MANDOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mandol, and when can generic versions of Mandol launch?
Mandol is a drug marketed by Lilly and is included in two NDAs.
The generic ingredient in MANDOL is cefamandole nafate. There are five drug master file entries for this compound. Additional details are available on the cefamandole nafate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MANDOL?
- What are the global sales for MANDOL?
- What is Average Wholesale Price for MANDOL?
Summary for MANDOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 1,674 |
| DailyMed Link: | MANDOL at DailyMed |
US Patents and Regulatory Information for MANDOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 062560-001 | Sep 10, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 062560-002 | Sep 10, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
